P-glycoprotein Inhibition: The Past, the Present and the Future

By  

Current Drug Metabolism, Vol. 12, Iss. 8, 2011-10 ,pp. : 722-731

Bentham Science Publishers

Access to resources Recommend Favorite

Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells

By Takano M.   Hasegawa R.   Fukuda T.   Yumoto R.   Nagai J.   Murakami T.  

European Journal of Pharmacology, Vol. 358, Iss. 3, 1998-10 ,pp. : 289-294

Elsevier

Access to resources Recommend Favorite

Tissue plasminogen activator inhibits P-glycoprotein activity in brain endothelial cells

By Deli M.A.   Abraham C.S.   Takahata H.   Niwa M.  

European Journal of Pharmacology, Vol. 411, Iss. 1, 2001-05 ,pp. : 3-5

Elsevier

Access to resources Recommend Favorite

The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel

By Crowe A.  

European Journal of Pharmacology, Vol. 440, Iss. 1, 2002-04 ,pp. : 7-16

Elsevier

Access to resources Recommend Favorite

P-Glycoprotein - Implications of Metabolism of Neoplastic Cells and Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 5, Iss. 6, 2005-09 ,pp. : 457-468

Bentham Science Publishers

Access to resources Recommend Favorite